Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods and reagents for the diagnosis, prevention and treatment of insulin resistance using beta-arrestin2 and its up-regulators

Methods and reagents for the diagnosis, prevention and treatment of insulin resistance using beta-arrestin2 and its up-regulators

US Patent 8536121 · Granted Sep 17, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nitrogen-containing heterocyclic compound and use thereof2025
Somatostatin subtype-2 receptor (SST2R) targeted therapeutics and uses thereof2024
Bond-selective intensity diffraction tomography and uses thereof2024
Therapeutic drug for neurodegenerative disease and application thereof2023
Somatostatin modulators and uses thereof2023
Compound for preventing or treating neurodegenerative disease and application th2023
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof2023
Tumor targeting polypeptide and method of use thereof2023
Nonpeptide somatostatin type 5 receptor agonists and uses thereof2022
Somatostatin modulators and uses thereof2022
Medical detectors and medical imaging devices2022
Insecticidal proteins and methods for their use2021